Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30
Published September 26, 2018 · Recall initiated: September 11, 2018
Summary
FDA records drug Class II recall D-1204-2018, published September 26, 2018 and initiated September 11, 2018. Recalling firm: Torrent Pharma Inc.; Status: Terminated; Reported quantity: 15,384 30-count bottles; Lot: Lot: BFR5D002 EXP 11-2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if LAMOTRIGINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LAMOTRIGINE
- Manufacturer
- Torrent Pharma Inc.
- Distributor
- Nationwide USA
- UPC
- 0313668342307
- Lot
- Lot: BFR5D002 EXP 11-2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TNAugust 17, 2022
- FDALamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDCJune 10, 2020
- FDALamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd.February 19, 2020
- FDAArthritis Pain Relief Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, DistributedSeptember 26, 2018
- FDAMethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc.September 26, 2018
- FDALamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem LaboratoriesOctober 5, 2016
Questions about this recall
Was Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30 recalled?
Yes. FDA published recall D-1204-2018 on September 26, 2018. Reported hazard: Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LAMOTRIGINE. UPC: 0313668342307.